Study on a new antidiabetic agent, glibenclamide (HB419). A clinical evaluation and comparative study.
D000328:Adult; D000368:Aged; D002747:Chlorpropamide / Q000627:therapeutic use; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D007004:Hypoglycemic Agents; D005905:Glyburide; D002747:Chlorpropamide